脓毒症发病时较高的IgA和IgG水平与较高死亡率相关:来自ALBIOS试验的结果
本研究为ALBIOS多中心开放标签RCT的子集分析,纳入956例重症脓毒症或脓毒性休克患者,于入组后第1、2、7天连续采集静脉血,检测IgA、IgG和IgM浓度。结果显示,第1天IgA对28天死亡率(HR 1.50,95%CI 1.18-1.92)和90天死亡率(HR 1.54,95%CI 1.25-1.91)有显著预测价值;第1天IgG对28天死亡率(HR 1.83,95%CI 1.33-2.51)和90天死亡率(HR 1.66,95%CI 1.23-2.25)也有类似结果,而IgM无此关联。此外,第1天较低的IgG水平与继发感染风险显著升高相关(533 [406-772] vs 600 [452-842] mg/dL,中位数[Q1-Q3],p=0.007)。作者认为,检测内源性免疫球蛋白可能有助于识别高死亡风险的脓毒症患者。
要点
- 第1天IgA水平对28天死亡率(HR 1.50,95%CI 1.18-1.92)和90天死亡率(HR 1.54,95%CI 1.25-1.91)有显著预测价值。
- 第1天IgG水平对28天死亡率(HR 1.83,95%CI 1.33-2.51)和90天死亡率(HR 1.66,95%CI 1.23-2.25)有显著预测价值。
- 第1天IgM水平与28天和90天死亡率均无显著关联。
- 第1天较低的IgG水平与继发感染风险显著升高相关(533 [406-772] vs 600 [452-842] mg/dL,p=0.007)。
- 作者认为,评估内源性免疫球蛋白可能有助于识别高死亡风险的脓毒症患者。
适用人群与场景
- ALBIOS试验中956例重症脓毒症和脓毒性休克患者(多中心、开放标签RCT子集)。
- 第1天所有患者检测IgA、IgG、IgM;第2天和第7天在150例患者亚组中检测。
- 样本于入组后第1、2、7天(或ICU出院,以先到者为准)连续采集静脉血。
研究设计与关键结果
- 研究类型:多中心、开放标签RCT(ALBIOS)子集分析;样本量956例;人群为重症脓毒症和脓毒性休克患者。
- 第1天IgA对28天死亡率HR 1.50(95%CI 1.18-1.92),对90天死亡率HR 1.54(95%CI 1.25-1.91)。
- 第1天IgG对28天死亡率HR 1.83(95%CI 1.33-2.51),对90天死亡率HR 1.66(95%CI 1.23-2.25)。
- 第1天IgM与28天和90天死亡率均无显著关联。
- 第1天较低的IgG水平与继发感染风险显著升高相关:533 [406-772] mg/dL vs 600 [452-842] mg/dL(中位数[Q1-Q3]),p=0.007。
- 免疫球蛋白浓度采用比浊法(OSR61171系统)测定。
- 试验注册号NCT00707122,Clinicaltrial.gov,2008年6月30日注册。
证据类型、等级与局限
- 证据类型:多中心、开放标签RCT(ALBIOS)的子集分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,评估内源性免疫球蛋白可能有助于识别高死亡风险的脓毒症患者。
- 原文未据此给出关于IVIG使用的推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The role of intravenous immunoglobulins (IVIG) during sepsis is controversial, as different trials on IVIG have observed inconsistent survival benefits. We aimed to elucidate the possible association and clinical significance between circulating levels of immunoglobulins.
METHODS: In a subset of 956 patients with severe sepsis and septic shock of the multicentre, open-label RCT ALBIOS, venous blood samples were serially collected 1, 2, and 7 days after enrolment (or at ICU discharge, whichever came first). IgA, IgG and IgM concentrations were assayed in all patients on day 1 and in a subgroup of 150 patients on days 2 and 7. Ig concentrations were measured employing a turbidimetric assay, OSR61171 system.
RESULTS: IgA on day 1 had a significant predictive value for both 28-day and 90-day mortality (28-day mortality, HR: 1.50 (95% CI 1.18-1.92); 90-day mortality, HR: 1.54 (95% CI 1.25-1.91)). IgG, but not IgM, on day 1 showed similar results for 28-day (HR 1.83 (95% CI 1.33-2.51) and 90-day mortality HR: 1.66 (95% CI 1.23-2.25)). In addition, lower levels of IgG but not of IgA and IgM, at day 1 were associated with significantly higher risk of secondary infections (533 [406-772] vs 600 [452-842] mg/dL, median [Q1-Q3], p = 0.007).
CONCLUSIONS: In the largest cohort study of patients with severe sepsis or septic shock, we found that high levels of IgA and IgG on the first day of diagnosis were associated with a decreased 90-day survival. No association was found between IgM levels and survival. As such, the assessment of endogenous immunoglobulins could be a useful tool to identify septic patients at high risk of mortality. Trial registration #NCT00707122, Clinicaltrial.gov, registered 30 June 2008.
参考来源
- Alagna L, Meessen JMTA, Bellani G, et al. Higher levels of IgA and IgG at sepsis onset are associated with higher mortality: results from the Albumin Italian Outcome Sepsis (ALBIOS) trial. Ann Intensive Care. 2021. PMID: 34825972. doi:10.1186/s13613-021-00952-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。